The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared to no beta-blocker treatment.
By Pooja Toshniwal PahariaApr 8 2024Reviewed by Susha Cheriyedath, M.Sc.
There is a lack of data from recent randomized clinical studies on the efficacy of long-term use of beta-blockers among acute myocardial infarction patients with intact ejection fraction. Previous Cochrane reviews underscore the need for novel research studies in this target population. Despite the absence of convincing scientific evidence of medication benefit, current recommendations strongly advocate beta-blocker therapy following a myocardial infarction.
All participants had obstructive coronary heart disease, as determined from coronary angiographies before randomization. The primary outcome was the composite measure of all-cause or incident MI-related mortality. Secondary outcomes included cardiovascular disease-related mortality and hospital admission for atrial fibrillations or heart failure.
Related StoriesCoronary angiography showed one-vessel involvement among 55% of MI patients, two vessels involved among 27%, and three vessels involved among 17% of patients. The team performed percutaneous coronary interventions in 96% of patients, with coronary artery bypass grafting among 3.9%. At hospital discharge, 97% received aspirin, P2Y12 receptor blockers, angiotensin-converting enzyme inhibitors, and statins.
Heart Attack Angiography Asthma Bradycardia Cardiovascular Disease Efficacy Heart Disease Heart Failure Hospital Hypotension Medicine Mortality Myocardial Infarction Pacemaker Research Stroke
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Beta blockers help only HALF of heart attack patients, landmark trial findsAround 60,000 people are prescribed beta blockers every year in the UK. But a trial has found that, for about half of patients, they do not reduce the risk of death or further heart attacks.
続きを読む »
Study finds treating heart attack patients with beta-blockers may be unnecessaryHalf of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. This is according to a new study published in the New England Journal of Medicine.
続きを読む »
Study Finds Empagliflozin Does Not Significantly Reduce Heart Failure Hospitalizations or Death After Heart AttackThe use of the SGLT-2 inhibitor empagliflozin after a heart attack did not show a significant benefit in reducing overall heart failure hospitalizations or death from any cause, according to a study presented at the American College of Cardiology's Annual Scientific Session. However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack.
続きを読む »
Preliminary research suggests improving and maintaining heart health after pregnancy may reduce the risk of CVDWomen with a history of adverse pregnancy complications are at significantly higher risk of developing heart disease but can reduce their risk by maintaining optimal heart health after pregnancy, according to preliminary research presented at the American Heart Association's Epidemiology and Prevention&9474;Lifestyle and Cardiometabolic...
続きを読む »
Act on mystery chest pain to reduce risk of heart attack, researchers urgeFuture heart attacks could be better prevented in people visiting their GP with unexplained chest pain, after Keele researchers developed the clearest picture yet of the factors that put them at higher risk. The research is published in the European Journal of Preventive Cardiology.
続きを読む »
Wuxia adventure Where Winds Meet gets limited beta test this monthEd has an interest in streaming, people and communities, and giving a voice to marginalised people.
続きを読む »